{"entity":{"type":"insider","cik":"0001711463","url":"/insider/0001711463","json_url":"/insider/0001711463.json","name":"Harris Todd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":21,"first":"2018-03-09","last":"2024-10-22","span_basis":"filed_date"},"name_variants":[{"name":"Harris Todd","source":"filing","n_filings":21,"first_seen":"2018-03-09","last_seen":"2024-10-22"}],"transactions":[{"id":2951937,"accession":"0000950170-24-116345","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-116345","line_url":"/filing/0000950170-24-116345","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19084.0,"shares_display":"19,084","price_per_share":27.90039834416265,"price_display":"27.90","price_state":"stated","total_value":532451.202,"total_display":"532,451.20","total_whole":"532,451","shares_owned_after":1355927.0,"shares_owned_after_display":"1,355,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-21","filed_date":"2024-10-22","scope":"insider","n_lines":2},{"id":2951919,"accession":"0000950170-24-116345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-116345","line_url":"/filing/0000950170-24-116345#line-1","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43636.0,"shares_display":"43,636","price_per_share":27.0143,"price_display":"27.01","price_state":"stated","total_value":1178795.9948,"total_display":"1,178,795.99","total_whole":"1,178,796","shares_owned_after":1375011.0,"shares_owned_after_display":"1,375,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":3152902,"accession":"0000950170-24-115432","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-115432","line_url":"/filing/0000950170-24-115432","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15394.0,"shares_display":"15,394","price_per_share":25.84589879173704,"price_display":"25.85","price_state":"stated","total_value":397871.766,"total_display":"397,871.77","total_whole":"397,872","shares_owned_after":1418847.0,"shares_owned_after_display":"1,418,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-17","scope":"insider","n_lines":2},{"id":3152900,"accession":"0000950170-24-115432","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-115432","line_url":"/filing/0000950170-24-115432","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33297.0,"shares_display":"33,297","price_per_share":26.171416668168302,"price_display":"26.17","price_state":"stated","total_value":871429.6608,"total_display":"871,429.66","total_whole":"871,430","shares_owned_after":1437963.0,"shares_owned_after_display":"1,437,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-17","scope":"insider","n_lines":3},{"id":3152897,"accession":"0000950170-24-115432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-115432","line_url":"/filing/0000950170-24-115432#line-1","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10035.0,"shares_display":"10,035","price_per_share":24.3119,"price_display":"24.31","price_state":"stated","total_value":243969.9165,"total_display":"243,969.92","total_whole":"243,970","shares_owned_after":1467338.0,"shares_owned_after_display":"1,467,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider"},{"id":2177918,"accession":"0000950170-24-111702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-111702","line_url":"/filing/0000950170-24-111702#line-1","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":1477373.0,"shares_owned_after_display":"1,477,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-10-02","scope":"insider"},{"id":2650321,"accession":"0000950170-24-109410","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-109410","line_url":"/filing/0000950170-24-109410#line-3","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":24.01,"price_display":"24.01","price_state":"stated","total_value":14406.0,"total_display":"14,406.00","total_whole":"14,406","shares_owned_after":1477873.0,"shares_owned_after_display":"1,477,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-25","filed_date":"2024-09-25","scope":"insider"},{"id":2650316,"accession":"0000950170-24-109410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-109410","line_url":"/filing/0000950170-24-109410#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1055.0,"shares_display":"1,055","price_per_share":24.0196,"price_display":"24.02","price_state":"stated","total_value":25340.678,"total_display":"25,340.68","total_whole":"25,341","shares_owned_after":1478473.0,"shares_owned_after_display":"1,478,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2024-09-25","scope":"insider"},{"id":2650312,"accession":"0000950170-24-109410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-109410","line_url":"/filing/0000950170-24-109410#line-1","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10092.0,"shares_display":"10,092","price_per_share":24.1257,"price_display":"24.13","price_state":"stated","total_value":243476.5644,"total_display":"243,476.56","total_whole":"243,477","shares_owned_after":1479528.0,"shares_owned_after_display":"1,479,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-25","scope":"insider"},{"id":2638837,"accession":"0000950170-24-108533","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-108533","line_url":"/filing/0000950170-24-108533#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7109.0,"shares_display":"7,109","price_per_share":24.1877,"price_display":"24.19","price_state":"stated","total_value":171950.3593,"total_display":"171,950.36","total_whole":"171,950","shares_owned_after":1489620.0,"shares_owned_after_display":"1,489,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-20","scope":"insider"},{"id":2638831,"accession":"0000950170-24-108533","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-108533","line_url":"/filing/0000950170-24-108533","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5698.0,"shares_display":"5,698","price_per_share":24.30516948051948,"price_display":"24.31","price_state":"stated","total_value":138490.8557,"total_display":"138,490.86","total_whole":"138,491","shares_owned_after":1496756.0,"shares_owned_after_display":"1,496,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-19","filed_date":"2024-09-20","scope":"insider","n_lines":2},{"id":2638820,"accession":"0000950170-24-108533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-108533","line_url":"/filing/0000950170-24-108533#line-1","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":84000.0,"total_display":"84,000.00","total_whole":"84,000","shares_owned_after":1502427.0,"shares_owned_after_display":"1,502,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-20","scope":"insider"},{"id":2274160,"accession":"0000950170-24-011879","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011879","line_url":"/filing/0000950170-24-011879#line-3","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13817.0,"shares_display":"13,817","price_per_share":16.9668,"price_display":"16.97","price_state":"stated","total_value":234430.2756,"total_display":"234,430.28","total_whole":"234,430","shares_owned_after":1502697.0,"shares_owned_after_display":"1,502,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":2274158,"accession":"0000950170-24-011879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-011879","line_url":"/filing/0000950170-24-011879","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86183.0,"shares_display":"86,183","price_per_share":16.495768605177354,"price_display":"16.50","price_state":"stated","total_value":1421654.8257,"total_display":"1,421,654.83","total_whole":"1,421,655","shares_owned_after":1523701.0,"shares_owned_after_display":"1,523,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-06","scope":"insider","n_lines":2},{"id":7922651,"accession":"0001209191-23-039807","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-039807","line_url":"/filing/0001209191-23-039807","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20712.0,"shares_display":"20,712","price_per_share":17.007585853611435,"price_display":"17.01","price_state":"stated","total_value":352261.1182,"total_display":"352,261.12","total_whole":"352,261","shares_owned_after":1607757.0,"shares_owned_after_display":"1,607,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider","n_lines":2},{"id":7922647,"accession":"0001209191-23-039807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-039807","line_url":"/filing/0001209191-23-039807","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3478.0,"shares_display":"3,478","price_per_share":17.03596940770558,"price_display":"17.04","price_state":"stated","total_value":59251.1016,"total_display":"59,251.10","total_whole":"59,251","shares_owned_after":1622488.0,"shares_owned_after_display":"1,622,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-26","scope":"insider","n_lines":2},{"id":8043235,"accession":"0001209191-23-038945","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-038945","line_url":"/filing/0001209191-23-038945","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19756.0,"shares_display":"19,756","price_per_share":17.360381398056287,"price_display":"17.36","price_state":"stated","total_value":342971.6949,"total_display":"342,971.69","total_whole":"342,972","shares_owned_after":1626566.0,"shares_owned_after_display":"1,626,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-21","scope":"insider","n_lines":3},{"id":8043228,"accession":"0001209191-23-038945","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-038945","line_url":"/filing/0001209191-23-038945#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":16.5333,"price_display":"16.53","price_state":"stated","total_value":21493.29,"total_display":"21,493.29","total_whole":"21,493","shares_owned_after":1645222.0,"shares_owned_after_display":"1,645,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8043226,"accession":"0001209191-23-038945","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-038945","line_url":"/filing/0001209191-23-038945","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54754.0,"shares_display":"54,754","price_per_share":17.041259451364283,"price_display":"17.04","price_state":"stated","total_value":933077.12,"total_display":"933,077.12","total_whole":"933,077","shares_owned_after":1647122.0,"shares_owned_after_display":"1,647,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider","n_lines":3},{"id":8652871,"accession":"0001209191-23-037613","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-037613","line_url":"/filing/0001209191-23-037613#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12773.0,"shares_display":"12,773","price_per_share":16.1275,"price_display":"16.13","price_state":"stated","total_value":205996.5575,"total_display":"205,996.56","total_whole":"205,997","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-15","scope":"insider"},{"id":8652866,"accession":"0001209191-23-037613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037613","line_url":"/filing/0001209191-23-037613#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7927.0,"shares_display":"7,927","price_per_share":16.0048,"price_display":"16.00","price_state":"stated","total_value":126870.0496,"total_display":"126,870.05","total_whole":"126,870","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":7918354,"accession":"0001209191-23-023402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023402","line_url":"/filing/0001209191-23-023402#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":16.126,"price_display":"16.13","price_state":"stated","total_value":32252.0,"total_display":"32,252.00","total_whole":"32,252","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8289616,"accession":"0001209191-23-021947","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-021947","line_url":"/filing/0001209191-23-021947#line-6","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.046,"price_display":"16.05","price_state":"stated","total_value":8023.0,"total_display":"8,023.00","total_whole":"8,023","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-03-31","scope":"insider"},{"id":8289608,"accession":"0001209191-23-021947","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-021947","line_url":"/filing/0001209191-23-021947#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2407.0,"shares_display":"2,407","price_per_share":16.0166,"price_display":"16.02","price_state":"stated","total_value":38551.9562,"total_display":"38,551.96","total_whole":"38,552","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-03-31","scope":"insider"},{"id":8289600,"accession":"0001209191-23-021947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-021947","line_url":"/filing/0001209191-23-021947#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1420.0,"shares_display":"1,420","price_per_share":16.1835,"price_display":"16.18","price_state":"stated","total_value":22980.57,"total_display":"22,980.57","total_whole":"22,981","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-31","scope":"insider"},{"id":8072100,"accession":"0001209191-23-021443","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-021443","line_url":"/filing/0001209191-23-021443#line-6","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2779.0,"shares_display":"2,779","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":44464.0,"total_display":"44,464.00","total_whole":"44,464","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-28","scope":"insider"},{"id":8072092,"accession":"0001209191-23-021443","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-021443","line_url":"/filing/0001209191-23-021443#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2963.0,"shares_display":"2,963","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":47408.0,"total_display":"47,408.00","total_whole":"47,408","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-28","scope":"insider"},{"id":8072085,"accession":"0001209191-23-021443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-021443","line_url":"/filing/0001209191-23-021443#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170.0,"shares_display":"170","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2720.0,"total_display":"2,720.00","total_whole":"2,720","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-28","scope":"insider"},{"id":8331836,"accession":"0001209191-23-020848","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-020848","line_url":"/filing/0001209191-23-020848#line-6","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":44800.0,"total_display":"44,800.00","total_whole":"44,800","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-23","scope":"insider"},{"id":8331828,"accession":"0001209191-23-020848","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-020848","line_url":"/filing/0001209191-23-020848#line-4","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4043.0,"shares_display":"4,043","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":64688.0,"total_display":"64,688.00","total_whole":"64,688","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-23","scope":"insider"},{"id":8331818,"accession":"0001209191-23-020848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-020848","line_url":"/filing/0001209191-23-020848#line-2","is_derivative":false,"issuer_cik":"0001711463","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001711463","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12393.0,"shares_display":"12,393","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":198288.0,"total_display":"198,288.00","total_whole":"198,288","shares_owned_after":1701276.0,"shares_owned_after_display":"1,701,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":6793612,"accession":"0001562180-18-002144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-18-002144","line_url":"/filing/0001562180-18-002144#line-1","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":570991.0,"shares_owned_after_display":"570,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-30","filed_date":"2018-05-02","scope":"insider"},{"id":6402214,"accession":"0001562180-18-001976","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-001976","line_url":"/filing/0001562180-18-001976#line-3","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":571091.0,"shares_owned_after_display":"571,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-25","filed_date":"2018-04-25","scope":"insider"},{"id":6402212,"accession":"0001562180-18-001976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001976","line_url":"/filing/0001562180-18-001976#line-2","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":571391.0,"shares_owned_after_display":"571,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-25","scope":"insider"},{"id":6402209,"accession":"0001562180-18-001976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-18-001976","line_url":"/filing/0001562180-18-001976#line-1","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":525.0,"shares_display":"525","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","total_whole":"10,500","shares_owned_after":571541.0,"shares_owned_after_display":"571,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-25","scope":"insider"},{"id":6735224,"accession":"0001140361-18-019087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-019087","line_url":"/filing/0001140361-18-019087#line-2","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15810.0,"shares_display":"15,810","price_per_share":20.0885,"price_display":"20.09","price_state":"stated","total_value":317599.185,"total_display":"317,599.18","total_whole":"317,599","shares_owned_after":572066.0,"shares_owned_after_display":"572,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-18","filed_date":"2018-04-19","scope":"insider"},{"id":6735220,"accession":"0001140361-18-019087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-019087","line_url":"/filing/0001140361-18-019087#line-1","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2201.0,"shares_display":"2,201","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":44020.0,"total_display":"44,020.00","total_whole":"44,020","shares_owned_after":587876.0,"shares_owned_after_display":"587,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-17","filed_date":"2018-04-19","scope":"insider"},{"id":6543858,"accession":"0001140361-18-018411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-018411","line_url":"/filing/0001140361-18-018411#line-1","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711463","owner_name":"Harris Todd","owner_display_name":"Harris Todd","owner_url":"/insider/0001711463","role":"Director, Officer (Head of Corporate Development)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3779.0,"shares_display":"3,779","price_per_share":20.0161,"price_display":"20.02","price_state":"stated","total_value":75640.8419,"total_display":"75,640.84","total_whole":"75,641","shares_owned_after":590077.0,"shares_owned_after_display":"590,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-10","filed_date":"2018-04-12","scope":"insider"}],"collapsed":true,"next_cursor":"2018-04-10|6543858","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":57,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2023-03-23","last_seen":"2024-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001656328","name":"Sienna Biopharmaceuticals, Inc.","url":"/issuer/0001656328","role":"Director, Officer (Head of Corporate Development)","n_filings":8,"first_seen":"2018-03-09","last_seen":"2018-05-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001711463","retrieved_at":"2026-08-26T05:05:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}